Theorem Clinical Research

Global News

AstraZeneca to collaborate with Singapore research organizations on heart failure

Wednesday, March 11, 2015 12:26 PM

AstraZeneca has formed a two-year collaboration with Singapore organizations including the Agency for Science, Technology and Research (A*STAR), National University Heart Center, Singapore (NUHCS) and National University of Singapore to support research into new therapies for heart failure.

More... »

Quest Diagnostics

Illumina, Merck Serono collaborate to expand companion diagnostics for oncology

Wednesday, March 11, 2015 12:22 PM

Illumina, a San Diego-based provider of sequencing and array-based technologies, has formed a collaboration with Merck Serono, the biopharmaceuticals business of Merck, based in Darmstadt, Germany, to develop a universal next-generation sequencing (NGS)-based oncology diagnostic.

More... »


MedImmune, Joslin Diabetes Center collaborate on metabolic disease research

Wednesday, March 11, 2015 12:21 PM

MedImmune, the global biologics R&D arm of AstraZeneca, and Joslin Diabetes Center, a diabetes research and clinical care organization based in Boston, Mass., have inked a three-year research collaboration to develop new medicines for the treatment of diabetes, obesity and related metabolic disorders.

More... »

Biomedical Systems launches next generation eCOA technology

Wednesday, March 11, 2015 12:20 PM

Biomedical Systems, a global provider of centralized diagnostic services headquartered in St. Louis, Mo., launches its second generation clinical outcome assessment software offering three platforms to collect patient data. This new electronic patient recorded outcome (ePRO) technology improves patient and investigator user experience, improves patient compliance and expedites study setup by simplifying site tasks and reducing errors.

More... »

CROS NT extends Datatrak Connect partnership

Monday, March 9, 2015 12:24 PM

CROS NT, an international CRO based in Chapel Hill, N.C., is extending its partnership with Datatrak, a worldwide technology and services company, as part of its life science technology portfolio. The partnership allows CROS NT to provide Datatrak's Unified eClinical platform, which includes Electronic Data Capture (EDC), Clinical Trial Management System (CTMS), randomization and clinical trial supply management (RTSM), as well as a web-based patient diary (ePRO).

More... »

Biomarkers Across Neurodegenerative Diseases launches $2M funding cycle

Monday, March 9, 2015 12:15 PM

Biomarkers Across Neurodegenerative Diseases (BAND) is launching a new funding cycle of nearly $2 million for projects investigating the overlap in the biology and clinical symptoms of Alzheimer's, Parkinson's, frontotemporal dementia (FTD) and other brain-deteriorating diseases.

More... »

Biosimilars Provide New Business Opportunities for Sites

Monday, March 9, 2015 08:00 AM

Significant factors involved in the growth and potential impact of biosimilars include budgetary pressures to reduce healthcare expenditures, patent expiries of blockbuster drugs, growing demand for low-cost alternatives, an increasingly aging population, government initiatives and rising incidences of various diseases.

More... »

NIH-led effort launches Big Data portal for Alzheimer’s drug discovery

Friday, March 6, 2015 12:16 PM

A NIH-led public-private partnership to transform and accelerate drug development has launched a new Alzheimer’s Big Data portal—including delivery of the first wave of data—for use by the research community. The new data sharing and analysis resource is part of the Accelerating Medicines Partnership (AMP), an unprecedented venture bringing together NIH, FDA, industry and academic scientists from a variety of disciplines to translate knowledge faster and more successfully into new therapies.

More... »

Mallinckrodt Pharmaceuticals to acquire Ikaria

Friday, March 6, 2015 12:14 PM

Mallinckrodt, a global specialty biopharmaceutical company based in Dublin, through a subsidiary, will acquire Hampton, N.J.-based Ikaria, a privately held critical care company, from a Madison Dearborn-led investor group, in a transaction valued at approximately $2.3 billion.

More... »

The Bill & Melinda Gates Foundation, CureVac collaborate

Friday, March 6, 2015 12:11 PM

The Bill & Melinda Gates Foundation has made a commitment to invest $52 million in CureVac, a Germany-based, clinical-stage biopharmaceutical company specializing in mRNA-based vaccine technologies.

More... »

`

CWWeekly

March 30

Icon, Carnegie Mellon partner to research ways to improve study patients' understanding of Informed Consent

Veeva launches OpenKey, partner program to unlock difficult access to, restrictions on customer reference data

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

March

Novo Nordisk, Takeda, Servier, Celgene among top sponsors
New gains seen from patient- and site-centric initiatives

Patient reported outcomes take center stage
FDA combining PROs, clinical outcomes in its approval decisions

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

February

Study grants market breaks $13 billion
Volume of clinical activity rising while growth in grant spending slows

Revisiting eClinical Technology Solutions Adoption
While use of established solutions grows, sponsors hesitate on newer tools

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs